PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV have been selected for poster presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 2012 in Chicago, IL, from June 1-5, 2012, at the McCormick Place Convention Center.
